Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone-Maintained Smokers Switching to E-Cigarettes
NCT05206435Phase 4Completed
- Sponsor
- Butler Hospital
- Start
- Mar 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in nicotine dependence (2 arms), sponsored by Butler Hospital. Primary endpoints: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol at 6 weeks, N'-nitrosonornicotine at 6 weeks and 1 more. Started Mar 2022; status: completed.
02
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT05206435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05206435.